Cargando…

Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations

A 47-year-old man was referred to our hospital with a 1-month history of fever and dyspnea after inhalation of insecticide in a confined space. We diagnosed rapidly progressive interstitial pneumonia. High-dose methylprednisolone, tacrolimus, and intermittent infusion of cyclophosphamide were admini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aoyama, Junichi, Hayashi, Hiroki, Yajima, Chika, Takoi, Hiroyuki, Tanaka, Toru, Kashiwada, Takeru, Kokuho, Nariaki, Terasaki, Yasuhiro, Nishikawa, Ayumi, Gono, Takahisa, Kuwana, Masataka, Saito, Yoshinobu, Abe, Shinji, Seike, Masahiro, Gemma, Akihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350262/ https://www.ncbi.nlm.nih.gov/pubmed/30723666 http://dx.doi.org/10.1016/j.rmcr.2019.01.012

Ejemplares similares

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease
por: Nishina, Naoshi, et al.
Publicado: (2020)

Mortality Risk Stratification Using Cluster Analysis in Patients With Myositis-Associated Interstitial Lung Disease Receiving Initial Triple-Combination Therapy
por: Gono, Takahisa, et al.
Publicado: (2022)

Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease
por: Kaieda, Shinjiro, et al.
Publicado: (2020)

A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab
por: Sugano, Teppei, et al.
Publicado: (2018)

Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer
por: Nishima, Shunichi, et al.
Publicado: (2020)

Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination
por: Kashiwada, Takeru, et al.
Publicado: (2022)

Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer
por: Sugano, Teppei, et al.
Publicado: (2020)

Prognostic Factors in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Retrospective Single-center Study
por: Atsumi, Kenichiro, et al.
Publicado: (2017)

Tertiary lymphoid structures in the primary tumor site of patients with cancer-associated myositis: A case–control study
por: Kadota, Hiroko, et al.
Publicado: (2023)

Editorial: Anti-MDA5-Positive Dermatomyositis
por: Gono, Takahisa, et al.
Publicado: (2022)

Abatacept downregulates Fcγ receptor I on circulating monocytes: a potential therapeutic mechanism in patients with rheumatoid arthritis
por: Fukue, Ryosuke, et al.
Publicado: (2022)

Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation
por: Kamio, Koichiro, et al.
Publicado: (2018)

Effect of Adding Inhaled Corticosteroid to Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist Therapy Among Patients With Chronic Obstructive Pulmonary Disease
por: Yuasa, Mizuki, et al.
Publicado: (2021)

Chylothorax after spinal fusion surgery: A case report and literature review
por: Toriyama, Kazutoshi, et al.
Publicado: (2019)

Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis
por: Tozuka, Takehiro, et al.
Publicado: (2018)

Pulmonary embolism and deep vein thrombosis in eosinophilic granulomatosis with polyangiitis successfully treated with rivaroxaban
por: Naito, Tomoyuki, et al.
Publicado: (2018)

A case of imatinib-related obstructive bronchiolitis followed long term
por: Yajima, Chika, et al.
Publicado: (2020)

Effect of H(2) treatment in a mouse model of rheumatoid arthritis‐associated interstitial lung disease
por: Terasaki, Yasuhiro, et al.
Publicado: (2019)

Early intervention of plasma exchange combined with intensive immunosuppressive treatment for anti-MDA-5 antibody–positive rapidly progressive interstitial pneumonia: Two case reports
por: Ishiwari, Mayuko, et al.
Publicado: (2021)

Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review
por: Suzuki, Ayana, et al.
Publicado: (2023)

Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Kawasumi, Hidenaga, et al.
Publicado: (2015)

Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report
por: Endo, Yushiro, et al.
Publicado: (2018)

Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan
por: Kawasumi, Hidenaga, et al.
Publicado: (2016)

Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis
por: Inomata, Minoru, et al.
Publicado: (2014)

Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression
por: Tozuka, Takehiro, et al.
Publicado: (2018)

Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders
por: Kuwana, Masataka, et al.
Publicado: (2021)

Impact of sarcopenia on chemotherapy‐triggered exacerbation of interstitial lung disease in patients with non‐small cell lung cancer
por: Kikuchi, Ryota, et al.
Publicado: (2021)

Spontaneous pulmonary hematoma with diffuse pulmonary ossification requiring emergency treatment: a case report
por: Sonokawa, Takumi, et al.
Publicado: (2019)

IL-6, IL-8, and IL-10 Are Associated with Hyperferritinemia in Rapidly Progressive Interstitial Lung Disease with Polymyositis/Dermatomyositis
por: Kawasumi, Hidenaga, et al.
Publicado: (2014)

Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
por: Shirai, Yuichiro, et al.
Publicado: (2021)

Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report
por: Kato, Yuki, et al.
Publicado: (2021)

A case of vildagliptin-induced interstitial pneumonia
por: Kuse, Naoyuki, et al.
Publicado: (2016)

Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
por: Kuwana, Masataka, et al.
Publicado: (2022)

Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease
por: Avouac, Jérôme, et al.
Publicado: (2020)

Clinical characteristics of anti‐MDA5 antibody‐positive interstitial lung disease
por: Kaenmuang, Punchalee, et al.
Publicado: (2020)

Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease
por: Selva-O’Callaghan, A., et al.
Publicado: (2021)

Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report
por: Hayashi, Anna, et al.
Publicado: (2022)

Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy
por: Gono, Takahisa, et al.
Publicado: (2013)

Roles of biomarkers in anti‐MDA5‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
por: Li, Xiaomeng, et al.
Publicado: (2022)

Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibody-associated vasculitis
por: Watanabe, Shinji, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oo31uteqs3s4ffrmmmnimsdhrq